Neuraxis Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
Analyst Coverage
2analysts covering
FY EPS (est.)
-$0.68next fiscal year
Monitoring Framework
Key Performance Indicators
Quarterly Revenue Quarterly1.6M
Gross Margin Quarterly8,640.0%
Quarterly Cash Burn Rate Quarterly1MTarget: 1000000 or less
Watch Items
- Payer Policy Coverage ExpansionTrigger: 100 million covered livesAction: Deepen commercial adoption in covered pediatric markets and secure written medical policy coverage from remaining commercial payers.
- Internal Prior Authorization Approval RateTrigger: 32% current rateAction: Target an increase in the pre-authorization approval rate to the 80% range to streamline patient access.
- Going Concern RiskTrigger: Auditor substantial doubtAction: Monitor cash runway, execute on the at-the-market equity facility, and drive toward the $15 million revenue cash flow breakeven trajectory.
Research as of 20 Jun 2026